See beyond your affiliate list
Discover websites, linked social accounts, publishers and potential sub-affiliate relationships connected to your partners. See the evidence behind each connection.
Follow changes across your pharma or healthcare partner ecosystem. Separate potential marketing issues, publisher opportunities and sampled AI-search citations into next actions for the right team.
Talk about partner intelligence ↗Discover websites, linked social accounts, publishers and potential sub-affiliate relationships connected to your partners. See the evidence behind each connection.
Monitor new pages, campaign activity, brand mentions and relevant social content. Focus on material changes and potential risks instead of repeating manual checks.
Spot relevant publisher pages where competing healthcare services appear but your brand does not. Assess new topics, placements and markets with the context in view.
Review publisher pages cited in sampled AI-assisted searches about your brand or service category. Find relevant publishers shaping those answers and gaps worth investigating.
Separate the changes that need correction from those worth exploring.
Partner and brand scope, priority changes, competitor context and any agreed sample of AI-search queries.
A structured view of partner activity: changes, potential marketing risks, relevant publisher opportunities and sampled AI citations, each with source context.
Compliance receives the wording to review; partnerships receives the publisher or change to investigate. Agree the delivery format and routing before rollout.
Observe new pages, relevant mentions and changes on supported channels.
A source-backed change record for the appropriate team.
Surface changed wording that matches configured checks.
A review signal with context, not a clinical or legal determination.
Compare relevant content with the brands and topics in scope.
The page and reason for a suitability-led commercial review.
Observe which publisher pages are cited in an agreed sample of AI-assisted searches.
Citation and available query/capture context. Not exhaustive AI coverage or a guarantee of inclusion.
Evaluate which findings lead to a useful review or partner action, which are irrelevant, and where scope or rules need adjustment.
A partner publishes a new service comparison, changes an eligibility claim and appears as a citation in a sampled AI answer.
Separate findings for the claim review, publisher opportunity and AI citation, each with its evidence and a suggested next action.
Put evidence behind your partner conversations, whether the next step is a correction or a new placement.
Find the pages, profiles and relationships connected to your partner network.
Review changes in activity, emerging risks and competitor coverage with the evidence in view.
Identify relevant publishers, missed placements and service topics worth exploring.
Delivery formats, access and supported integrations are agreed in your service scope. AI visibility is based on sampled queries, not exhaustive coverage.
It is visibility into what your partners publish and what changes around them: websites, supported social channels, brand mentions, competitor placements and sampled AI search citations.
Discuss the output your team needs, then confirm the currently available delivery options and any additional work in the written scope. Do not assume API access or a native integration from this page. Coverage and cadence are also agreed before monitoring starts.
No. AI answers vary by model, query, geography and time. Treato reports observations from the agreed sample, with the query and capture context. It does not promise complete coverage or guaranteed inclusion.
No. Your tracking platform handles attribution and programme administration. Treato adds visibility into partner content, activity and relationships.
A source inventory and observed connections to verify.
A potential mismatch against your approved reference.
A relevant publisher page and its coverage context.
Partner activity separated into review items and opportunities.
Partner Intelligence follows activity across discovery, risk and opportunity themes; the focused products address a specific job. They can use overlapping source material. We agree which products and outputs belong in your scope, rather than implying a fixed bundle or an additional licence requirement.
Pick the question, the sources and the measures your team will use to judge the result.
Tell us about your partner network. We’ll help you scope the right monitoring coverage.
Talk to Treato A conversation about your partners, markets and priorities.